Literature DB >> 11069656

The processing of a Benzo(a)pyrene adduct into a frameshift or a base substitution mutation requires a different set of genes in Escherichia coli.

N Lenne-Samuel1, R Janel-Bintz, A Kolbanovskiy, N E Geacintov, R P Fuchs.   

Abstract

Replication through a single DNA lesion may give rise to a panel of translesion synthesis (TLS) events, which comprise error-free TLS, base substitutions and frameshift mutations. In order to determine the genetic control of the various TLS events induced by a single lesion, we have chosen the major N2-dG adduct of (+)-anti-Benzo(a)pyrene diol epoxide [(+)-anti-BPDE] adduct located within a short run of guanines as a model lesion. Within this sequence context, in addition to the major event, i.e. error-free TLS, the adduct also induces base substitutions (mostly G --> T transversions) and -1 frameshift mutations. The pathway leading to G --> T base substitution mutagenesis appears to be SOS independent, suggesting that TLS is most probably performed by the replicative Pol III holoenzyme itself. In contrast, both error-free and frameshift TLS pathways are dependent upon SOS-encoded functions that belong to the pool of inducible DNA polymerases specialized in TLS (translesional DNA polymerases), namely umuDC (Pol V) and dinB (Pol IV). It is likely that, given the diversity of conformations that can be adopted by lesion-containing replication intermediates, cells use one or several translesional DNA polymerases to achieve TLS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11069656     DOI: 10.1046/j.1365-2958.2000.02116.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  26 in total

1.  Mechanism of DNA polymerase II-mediated frameshift mutagenesis.

Authors:  O J Becherel; R P Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

2.  The processivity factor beta controls DNA polymerase IV traffic during spontaneous mutagenesis and translesion synthesis in vivo.

Authors:  Nathalie Lenne-Samuel; Jérôme Wagner; Hélène Etienne; Robert P P Fuchs
Journal:  EMBO Rep       Date:  2001-12-19       Impact factor: 8.807

3.  The dinB operon and spontaneous mutation in Escherichia coli.

Authors:  Gregory J McKenzie; Daniel B Magner; Peter L Lee; Susan M Rosenberg
Journal:  J Bacteriol       Date:  2003-07       Impact factor: 3.490

4.  Role of Escherichia coli DNA polymerase IV in in vivo replication fidelity.

Authors:  Wojciech Kuban; Piotr Jonczyk; Damian Gawel; Karolina Malanowska; Roel M Schaaper; Iwona J Fijalkowska
Journal:  J Bacteriol       Date:  2004-07       Impact factor: 3.490

5.  Error-prone DNA polymerase IV is controlled by the stress-response sigma factor, RpoS, in Escherichia coli.

Authors:  Jill C Layton; Patricia L Foster
Journal:  Mol Microbiol       Date:  2003-10       Impact factor: 3.501

6.  RpoS, the stress response sigma factor, plays a dual role in the regulation of Escherichia coli's error-prone DNA polymerase IV.

Authors:  Kimberly A M Storvik; Patricia L Foster
Journal:  J Bacteriol       Date:  2010-05-14       Impact factor: 3.490

7.  Role of DNA polymerase IV in Escherichia coli SOS mutator activity.

Authors:  Wojciech Kuban; Magdalena Banach-Orlowska; Roel M Schaaper; Piotr Jonczyk; Iwona J Fijalkowska
Journal:  J Bacteriol       Date:  2006-09-15       Impact factor: 3.490

Review 8.  Biological properties of single chemical-DNA adducts: a twenty year perspective.

Authors:  James C Delaney; John M Essigmann
Journal:  Chem Res Toxicol       Date:  2007-12-12       Impact factor: 3.739

9.  Y-Family DNA polymerases may use two different dNTP shapes for insertion: a hypothesis and its implications.

Authors:  Sushil Chandani; Edward L Loechler
Journal:  J Mol Graph Model       Date:  2008-11-08       Impact factor: 2.518

10.  Amino acid architecture that influences dNTP insertion efficiency in Y-family DNA polymerase V of E. coli.

Authors:  Kwang Young Seo; Jun Yin; Prashant Donthamsetti; Sushil Chandani; Chui Hong Lee; Edward L Loechler
Journal:  J Mol Biol       Date:  2009-07-14       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.